Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-15
DOI
10.3389/fimmu.2019.01015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma
- (2018) Abner A. Murray et al. MOLECULAR PHARMACEUTICS
- Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy
- (2018) Neus Martinez-Bosch et al. Cancers
- Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination
- (2017) Mona O. Mohsen et al. JOURNAL OF CONTROLLED RELEASE
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines
- (2017) Ariane C. Gomes et al. Frontiers in Immunology
- Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer
- (2017) Braeden Donaldson et al. Journal for ImmunoTherapy of Cancer
- Bioorthogonal Copper Free Click Chemistry for Labeling and Tracking of Chondrocytes In Vivo
- (2016) Hwa In Yoon et al. BIOCONJUGATE CHEMISTRY
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
- (2016) Nayoung Lee et al. PATHOLOGY
- Click Chemistry Applied to the Synthesis of Salmonella Typhimurium O-Antigen Glycoconjugate Vaccine on Solid Phase with Sugar Recycling
- (2015) Giuseppe Stefanetti et al. BIOCONJUGATE CHEMISTRY
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Immune Infiltration and Prostate Cancer
- (2015) Amy Strasner et al. Frontiers in Oncology
- Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
- (2014) A. Makkouk et al. CANCER RESEARCH
- Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications
- (2014) Andy Rimmer et al. NATURE GENETICS
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Getting Personal with Neoantigen-Based Therapeutic Cancer Vaccines
- (2013) N. Hacohen et al. Cancer Immunology Research
- Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients
- (2013) Ryuji Okuyama et al. OncoImmunology
- Exploiting the Mutanome for Tumor Vaccination
- (2012) J. C. Castle et al. CANCER RESEARCH
- Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients
- (2012) Simone M. Goldinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Can the exome and the immunome converge on the design of efficient cancer vaccines?
- (2012) Guido Kroemer et al. OncoImmunology
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
- (2011) Yadvinder S. Ahi et al. CURRENT GENE THERAPY
- Cu-free click cycloaddition reactions in chemical biology
- (2010) John C. Jewett et al. CHEMICAL SOCIETY REVIEWS
- Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
- (2010) Daniel E. Speiser et al. JOURNAL OF IMMUNOTHERAPY
- Copper-free click chemistry in living animals
- (2010) P. V. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More